NCT04239261: A trial that was reported late by MercyOne Des Moines Medical Center
This trial has reported, although it was 54 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04239261 |
|---|---|
| Title | A Randomized, Placebo-Controlled, Pilot Study of Serum-Derived Bovine Immunoglobulin/Protein Isolate to Manage Mucositis in Patients Undergoing Treatment for Head, Neck, or Lung Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 17, 2020 |
| Completion date | Jan. 24, 2023 |
| Required reporting date | Jan. 24, 2024, midnight |
| Actual reporting date | March 18, 2024 |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | 54 |